173 related articles for article (PubMed ID: 3828211)
21. Long-term photochemotherapy for psoriasis: a histopathological and clinical follow-up study with special emphasis on tumour incidence and behavior of pigmented lesions.
Ros AM; Wennersten G; Lagerholm B
Acta Derm Venereol; 1983; 63(3):215-21. PubMed ID: 6192634
[TBL] [Abstract][Full Text] [Related]
22. Epidermal dystrophy and actinic keratoses in psoriasis patients following oral psoralen photochemotherapy (PUVA). Follow-up study.
Abel EA; Cox AJ; Farber EM
J Am Acad Dermatol; 1982 Sep; 7(3):333-40. PubMed ID: 7130492
[TBL] [Abstract][Full Text] [Related]
23. Ophthalmological study of patients undergoing long-term PUVA therapy.
Rönnerfält L; Lydahl E; Wennersten G; Jahnberg P; Thyresson-Hök M
Acta Derm Venereol; 1982; 62(6):501-5. PubMed ID: 6187155
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
[TBL] [Abstract][Full Text] [Related]
25. PUVA treatment and skin cancer: A follow-up study.
Lassus A; Reunala T; Idänpää-Heikkilä J; Juvakoski T; Salo O
Acta Derm Venereol; 1981; 61(2):141-5. PubMed ID: 6165190
[TBL] [Abstract][Full Text] [Related]
26. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance.
van de Kerkhof PC; de Rooij MJ
Br J Dermatol; 1997 Feb; 136(2):275-8. PubMed ID: 9068750
[TBL] [Abstract][Full Text] [Related]
27. p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms.
Proby CM; du Peloux Menagé H; McGregor JM; Hobbs C; Norris PG; Smith N; Hawk JL; McKee PH
J Cutan Pathol; 1993 Oct; 20(5):435-41. PubMed ID: 8300928
[TBL] [Abstract][Full Text] [Related]
28. Widespread cutaneous carcinomas associated with human papillomaviruses 5, 14 and 20 after introduction of methotrexate in two long-term PUVA-treated patients.
Zumtobel U; Schwarze HP; Favre M; Taïeb A; Delaunay M
Dermatology; 2001; 202(2):127-30. PubMed ID: 11306834
[TBL] [Abstract][Full Text] [Related]
29. PUVA-induced lymphomatoid papulosis in a patient with mycosis fungoides.
Wolf P; Cerroni L; Smolle J; Kerl H
J Am Acad Dermatol; 1991 Aug; 25(2 Pt 2):422-6. PubMed ID: 1894785
[TBL] [Abstract][Full Text] [Related]
30. Keratoses and nonmelanoma skin tumors in long-term photochemotherapy (PUVA).
Hönigsmann H; Wolff K; Gschnait F; Brenner W; Jaschke E
J Am Acad Dermatol; 1980 Oct; 3(4):406-14. PubMed ID: 7430462
[No Abstract] [Full Text] [Related]
31. The benefits and risks of long-term PUVA photochemotherapy.
Momtaz K; Fitzpatrick TB
Dermatol Clin; 1998 Apr; 16(2):227-34. PubMed ID: 9589196
[TBL] [Abstract][Full Text] [Related]
32. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
Berne B; Fischer T; Michaëlsson G; Norén P
Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
[TBL] [Abstract][Full Text] [Related]
33. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
Maier H; Schemper M; Ortel B; Binder M; Tanew A; Hönigsmann H
Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
[TBL] [Abstract][Full Text] [Related]
34. Comparative tolerability of systemic treatments for plaque-type psoriasis.
McClure SL; Valentine J; Gordon KB
Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213
[TBL] [Abstract][Full Text] [Related]
35. Skin cancer in the PUVA-48 cooperative study.
Roenigk HH; Caro WA
J Am Acad Dermatol; 1981 Mar; 4(3):319-24. PubMed ID: 7217399
[TBL] [Abstract][Full Text] [Related]
36. Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O
Acta Derm Venereol; 1981; 61(1):47-51. PubMed ID: 6164214
[TBL] [Abstract][Full Text] [Related]
37. Incidence of skin cancer in Japanese psoriatic patients treated with either methoxsalen phototherapy, Goeckerman regimen, or both therapies. A 10-year follow-up study.
Torinuki W; Tagami H
J Am Acad Dermatol; 1988 Jun; 18(6):1278-81. PubMed ID: 3385042
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous carcinoma in psoriatic patients treated with PUVA.
Reshad H; Challoner F; Pollock DJ; Baker H
Br J Dermatol; 1984 Mar; 110(3):299-305. PubMed ID: 6696845
[TBL] [Abstract][Full Text] [Related]
39. Side-effects of psoralen photochemotherapy (PUVA).
Wolff K
Br J Dermatol; 1990 Jun; 122 Suppl 36():117-25. PubMed ID: 2196078
[TBL] [Abstract][Full Text] [Related]
40. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
